Early Feasibility Study of the "Easy Light" Fluorecence Imaging System

NCT05004623CompletedNAINTERVENTIONAL

Summary

Key Facts

Lead Sponsor

Professor Fernando Figueira Integral Medicine Institute

Enrollment

5

Start Date

2021-05-26

Completion Date

2021-07-27

Study Type

INTERVENTIONAL

Official Title

Early Feasibility Study of an Open-Field Handheld Wireless Fluorecence Imaging System for Detection of Sentinel Lymph Nodes in Women With Cervical and Uterine Cancers

Interventions

Sentinel Lymph Node Biopsy

Conditions

Uterine Cervical NeoplasmsUterine Neoplasms

Eligibility

Age Range

18 Years – 70 Years

Sex

FEMALE

Inclusion Criteria:

1. Patients with biopsy-proven cervical or uterine cancers;
2. Clinical stage I or II, according to FIGO - The International Federation of Gynecology and Obstetrics;
3. Indication for sentinel lymph node biopsy with or without complementary lymphadenectomy by her medical assistant;
4. Performance status of 0-2;
5. No synchronous malignancies or previous oncological treatments such as radiation or major abdominal surgery;
6. Absence of neuro-psychiatric disorders, apparent or confirmed infections, history of drug allergies, limiting obesity for surgery, and pregnancy or breast feeding;
7. Appropriated cardio-respiratory, hepato-renal and hematological reserves;
8. Signing of the Consent Form.

Exclusion Criteria:

1\. Perioperative impossibility to inject the fluorescent dye indocyanine green in the cervical region due to any locorregional reason.

Outcome Measures

Primary Outcomes

The ability to detect sentinel lymph nodes.

The ability to detect at least one sentinel lymph node per patient during open surgeries.

Time frame: Intraoperativelly

Locations

IMIP - Instituo de Medicina Integral Professor Fernando Figueira, Recife, Brazil